DAFTAR PUSTAKA

Sumariyono. Diagnosis dan Tatalaksana Sindrom Sjorgen. Kumpulan Makalah

Temu Ilmiah Reumatologi. 2008.p134-6.
Yuliasih. Sindroma Sjogren. Buku Ajar Ilmu Penyakit Dalam. Jilid II edisi IV.
Pusat Penerbitan IPD FKUI 2006.p1193-6.
Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of
arthritis and other rheumatic conditions in the United States. Part I. Arthritis
Rheum. Jan 2008;58(1):15-25.
Fox PC. Autoimmune diseases and Sjgrens syndrome: an autoimmune
exocrinopathy. Ann. NY Acad. Sci.1098,2007;1521.
Kessel A, Toubi E, Rozenbaum M, Zisman D, Sabo E, Rosner I. Sjgrens
syndrome in the community: can serology replace salivary gland biopsy?
Rheumatol. Int. 2006;26,3379.
Kruszka P, OBrian RJ. Diagnosis and management of Sjgren syndrome. Am.
Fam. Physician. 2009;79,46570.
Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China.
Rheumatol. Int.2009;29,48190.
Price EJ, Venables PJ. The etiopathogenesis of Sjgrens syndrome. Semin
Arthritis Rheum. Oct 1995;25(2):117-33.
Mattey DL, Gonzlez-Gay MA, Hajeer AH, Dababneh A, Thomson W, Garca-
Porra C, et al. Association between HLA-DRB1*15 and secondary Sjgrens
syndrome in patients with rheumatoid arthritis. J Rheumatol. 2000;27(11):2611-6.
Papasteriades CA, Skopouli FN, Drosos AA, Andonopoulos AP, Moutsopoulos
HM. HLA-alloantigen associations in Greek patients with Sjgrens syndrome. J
Autoimmun. Feb 1988;1(1):85-90.
Parkin B, Chew JB, White VA, Garcia-Briones G, Chhanabhai M, Rootman J.
Lymphocytic infi ltration and enlargement of the lacrimal glands: a new subtype
of primary Sjgrens syndrome?. Ophthalmology. 2005;112(11):2040-7
Delaleu N, Jonsson MV, Appel S. New concepts in the pathogenesis of Sjogrens
syndrome. Rheum. Dis. Clin. North America, 2008.34(4);833-45.

Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman
DR, et al. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med.
2004;89(6):888-92.
De Monchy, I., Jonsson M.V., Appel, S., Jonsson R. New concepts in the
pathogenesis of Sjogrens syndrome. Rheum. Dis. Clin. North America.
2011:21(5),656-60.
Kalk, W.W., Mansour, K., Vissink, A., Spijkervet F.K., Bootsma, H., Kallenberg,
C.G.< et al. Oral and ocular manifestation in Sjogrens syndrome. J.
Rheumatology. 2002;29(5),924-30.
Foulks GN. The evolving treatment of dry eyes. Ophtalmol Clin North Am.
2003;16:29-35.
Wolkoff P, Nojgaard JK, Franck C., Skov P. The modern office environment
desiccates the eyes? Indoor Air. 2006;16:258-65.
Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al.
Comparison of autologous serum eye drops with conventional therapy in
randomized controlled crossover trial for ocular surface disease. Br J Ophtalmol.
2004;88:647-52.
Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular
surface disorder. Br J Ophtalmol 2004;88:1467-74.
Fox RI, Konttinen Y, Fisher A. Use of muscarinic agonists in the treatment of
Sjogrens syndrome. Clin Immunol. 2001;101:249-63.
Aikaterini TS, Judith AJ. Primary Sjogrens Syndrome: Current and Prospective
Therapies.Semin Arthritis Rheum. 2008;37:273-92.
Meijer JM, Pijpe J, Vissink A. Treatment of Primary Sjogren syndrome with
Rituximab; extended follow up, safety and efficacy of treatment. Ann. Rheum.
Dis. 2009;68:284-5.
Casals MR Font J. Primary Sjogren Syndrome: Current and emergent
aetiopathogenic concepts. Rheumatology. 2005;44:1354-67
Tsifetaki N, Kitsos CA, Paschides. Oral Pilocarpin for the treatment of ocular
symptoms in patient with Sjogren syndrome. A randomized controlled study. Ann.
Rheum Dis. 2003;62:1204-7.

Dawson L, Caulfi eld V, Hydroxychloroquine therapy in patient with primary

sjogren syndrome may improve salivary gland hypofunction by inhibition of
glandular cholinesterase. Rheumatology. 2005;44:449-55.